Clinical Trial Results:
Estudio fase II, abierto, multicéntrico, no comparativo, que evalúa la eficacia de Glivec® con Hidroxiurea en pacientes con Glioblastoma Multiforme (GBM) en progresión, que reciben fármacos anticonvulsivantes con capacidad de inducción enzimática
Summary
|
|
EudraCT number |
2005-002603-16 |
Trial protocol |
ES BE SE DE DK |
Global completion date |
19 Aug 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 Nov 2016
|
First version publication date |
19 Nov 2016
|
Other versions |
|
Summary report(s) |
CSTI571H2202.CTR.02Nov2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.